Market Place
Sourcing Support
Hetero Labs`s Generics Mycophenolate Mofetil Receives Approval in US
22 Oct 2024 //
FDA
Azurity Pharmaceuticals` MYHIBBIN™ gets FDA approval.
06 May 2024 //
PR NEWSWIRE
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus
31 Aug 2023 //
ECONOMICTIMES
Amneal Pharma`s Generic Mycophenolate Mofetil Receives Approvals in US
03 Nov 2021 //
FDA
Lannett introduces mycophenolate mofetil for oral suspension in US markets
01 Sep 2021 //
PHARMABIZ
FDA requests additional time for Flexion`s NDA
15 Oct 2019 //
ENDPTS
NIH funded study shows methotrexate is more effective than mycophenolate mofetil
13 Sep 2019 //
PHARMABIZ
Enforcement Report - Week of May 15, 2019
15 May 2019 //
FDA
Par Pharmaceutical recalls Mycophenolate Mofetil Injection, USP
04 May 2019 //
FDA
Par Pharma Issues Voluntary Recall of One Lot of Mycophenolate Mofetil for Inj
01 May 2019 //
PR NEWSWIRE
Vistapharm`s Generic Mycophenolate Mofetil Receives Approval in US
12 Feb 2019 //
FDA
EMA Assessment & Procedural Steps for Teva Pharma BV`s Mycophenolate mofetil
09 Oct 2018 //
EMA
Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.
30 Jul 2018 //
PATENT LITIGATION
Zhejiang Hisun Pharm’s Generic Mycophenolate Mofetil Receives Approval In US
16 Nov 2017 //
FDA
Japan`s MHLW slated to review Nippon Boehringer high blood pressure combo
13 Apr 2016 //
FIERCE PHARMA ASIA
Rituxan Scores in Rare Vasculitis
06 Apr 2015 //
MEDPAGE TODAY
CellCept,MYFORTIC-Risk of Teratogenicity in Mycophenolate-Containing Products
12 Jan 2015 //
HEALTH CANADA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.